Finance

Lists
002287:SHE
Tibet Cheezheng Tibetan Medicine Co Ltd
19,16 CN¥
-0,21%
(-0,040) 1D
16 қаз., 15:03:06 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002287...
Open
19,27 CN¥
High
19,64 CN¥
Low
19,01 CN¥
Mkt. cap
11,08 млрд
Avg. vol.
1,30 млн
Volume
2,06 млн
Dividend
3,34%
Quarterly dividend
0,16 CN¥
Ex-dividend date
2026 ж. 23 қыр.
P/E ratio
16,36
52-wk high
27,33 CN¥
52-wk low
18,33 CN¥
EPS
1,17 CN¥
Shares outstanding
572,12 млн
No. of employees
3 мың
Open
19,27 CN¥
High
19,64 CN¥
Low
19,01 CN¥
Mkt. cap
11,08 млрд
Avg. vol.
1,30 млн
Volume
2,06 млн
Dividend
3,34%
Quarterly dividend
0,16 CN¥
Ex-dividend date
2026 ж. 23 қыр.
P/E ratio
16,36
52-wk high
27,33 CN¥
52-wk low
18,33 CN¥
EPS
1,17 CN¥
Shares outstanding
572,12 млн
No. of employees
3 мың
News stories
From web sources and news partners
Profile
Tibet Cheezheng Tibetan Medicine, or Tibet Qizheng Tibetan Medicine Co., Ltd is a prominent firm in the Tibetan medicine sector in China, primarily focused on the research, development, manufacture, and sales of Tibetan medicinal products. Wikipedia
About Tibet Cheezheng Tibetan Medicine Co Ltd
CEO-
Employees3,2 мың
Founded1995
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
347,89 млн
893,07 млн
405,25 млн
572,72 млн
Cost of goods sold
61,48 млн
140,40 млн
65,12 млн
115,25 млн
Cost of revenue
61,48 млн
140,40 млн
65,12 млн
115,25 млн
Research and development expenses
17,52 млн
31,37 млн
14,95 млн
17,97 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
264,43 млн
467,36 млн
231,41 млн
178,28 млн
Operating expense
287,80 млн
506,73 млн
250,16 млн
208,55 млн
Total operating expenses
349,28 млн
647,13 млн
315,28 млн
323,80 млн
Operating income
-1,40 млн
245,94 млн
89,97 млн
248,92 млн
Other non operating income
269,69 м.
-863,06 м.
462,08 м.
169,34 м.
EBT including unusual items
69,67 млн
267,60 млн
109,04 млн
305,43 млн
EBT excluding unusual items
-8,28 млн
245,93 млн
90,15 млн
249,46 млн
Income tax expense
5,56 млн
43,69 млн
15,07 млн
29,25 млн
Effective tax rate
7,98%
16,33%
13,82%
9,58%
Other operating expenses
4,85 млн
9,39 млн
3,92 млн
11,87 млн
Net income
65,12 млн
224,91 млн
95,18 млн
276,12 млн
Net profit margin
18,72%
25,18%
23,49%
48,21%
Earnings per share
-
-
-
-
Interest and investment income
1,78 млн
3,52 млн
1,77 млн
1,74 млн
Interest expense
-9,89 млн
-2,55 млн
-2,05 млн
-1,81 млн
Net interest expenses
-8,11 млн
978,68 м.
-280,98 м.
-63,34 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
25,60 млн
279,82 млн
123,85 млн
283,96 млн
Gain or loss from assets sale
909,31 м.
-7,38 млн
-
-248,14 м.
AI content may include mistakes. Learn more
Google қолданбалары